BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barnett BS, Greer GR. Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer. J Acad Consult Liaison Psychiatry 2021;62:460-71. [PMID: 34210406 DOI: 10.1016/j.jaclp.2020.12.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Morton E, Sakai K, Ashtari A, Pleet M, Michalak EE, Woolley J. Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of 'magic mushroom' consumption. J Psychopharmacol 2023;37:49-60. [PMID: 36515370 DOI: 10.1177/02698811221131997] [Reference Citation Analysis]
2 Calleja-Conde J, Morales-García JA, Echeverry-Alzate V, Bühler KM, Giné E, López-Moreno JA. Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies. Addict Biol 2022;27:e13229. [PMID: 36301215 DOI: 10.1111/adb.13229] [Reference Citation Analysis]
3 Gowda MR. Psychedelics Road Ahead: Are We Ready? Indian Journal of Private Psychiatry 2022;16:1-2. [DOI: 10.5005/jp-journals-10067-0113] [Reference Citation Analysis]
4 Kapfhammer H. Onkologische Krankheiten. Depression, Angst, traumatischer Stress und internistische Erkrankungen 2022. [DOI: 10.1007/978-3-662-65873-4_12] [Reference Citation Analysis]
5 Williams ML, Korevaar D, Harvey R, Fitzgerald PB, Liknaitzky P, O'Carroll S, Puspanathan P, Ross M, Strauss N, Bennett-Levy J. Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead. Front Psychiatry 2021;12:737738. [PMID: 34803761 DOI: 10.3389/fpsyt.2021.737738] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]